Copyright 1999 American Medical Association.
All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.1999
To the Editor: Dr Celentano
and colleagues1 describe some interesting data. We
performed a cross-sectional study at the Catholic University in Rome,
Italy, to assess predictive factors associated with adherence to ART in
HIV-infected people receiving combination therapy with a PI. From April
1998 to July 1998, each consecutive HIV-infected patient attending the
outpatient clinic and receiving triple combination ART with indinavir
or ritonavir who provided informed consent was asked to fill out a
questionnaire that included questions on the ART scheme they were
currently taking (name, color, and timing), frequency and number of
missed doses, reminder methods, frequency of running out of pills,
reasons for treatment interruption, relationship with health care
staff, presence of symptoms, and sociodemographic characteristics.
Plasma level of PI as well as HIV viral load and CD4+ cell
count were determined for each enrolled person. Clinic records were
used to assess currently prescribed ART.
Murri R, Ammassari A, De Luca A, Cingolani A, Antinori A, Ortona L. Use of Antiretroviral Therapy by Intravenous Drug Users With HIV. JAMA. 1999;281(8):699–701. doi:10-1001/pubs.JAMA-ISSN-0098-7484-281-8-jbk0224
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: